RARE ultragenyx.com Earnings per share growth this year

Corporate emblem and logo of Ultragenyx Pharmaceutical (RARE)

Ultragenyx Pharmaceutical is creating synergy with biotech laboratories to develop gene therapies, which is attracting the attention of potential buyers. Partnerships with academic groups are accelerating the time-to-market for drugs. The year-over-year change in EPS demonstrates profitability dynamics, where the value of 75.40 characterizes this level. However, high R&D costs coupled with weak revenue are leading to the depletion of reserves and a search for external capital.

Net earnings per share growth this year: Ultragenyx Corp (RARE) for 07/04/2022 - 11/18/2026

Analytical breakdowns and data insights for company Ultragenyx Pharmaceutical (RARE)

- stock value and consensus price forecast:
Fundamental valuation:Ultragenyx Pharma (RARE)
Manufactured products of Ultragenyx Corp

Institutional capital assesses the investment attractiveness of Ultragenyx Pharmaceutical (RARE) through the company's ability to monetize unique developments from elite geneticists into tangible financial results. By analyzing the annual EPS growth rate, which measures the percentage change in net income per share compared to the previous year, investors determine the efficiency of research cost management and the asset's overall resilience to external market shocks.

Direct competitors

Tempus AI, Inc (TEM) - Earnings growth in current year|Earnings per share growth in current year Qiagen|IONS: Earnings per share increase in current year|Net earnings per share growth this year RGEN (Repligen)|Expected net earnings per share growth this year Avidity Biosciences Inc|Earnings growth in current year CRSP (crisprtx.com)|WGS: Earnings per share growth this year|BEAM - Earnings per share growth in current year|Earnings per share growth rate in current year sarepta.com|TWST: Earnings growth in current year|TXG - Expected net earnings per share growth this year|Earnings per share growth in current year Intellia|Earnings per share growth rate in current year Stoke Therapeutics STOK|Earnings growth in current year BLFS|Wave Life Sciences - Earnings per share growth this year|Earnings growth in current year MAZE (Maze Therapeutics, Inc.)|Earnings growth in current year Sionna Pharma SION|Prime Medicine Bio - Earnings growth in current year|Earnings per share increase in current year TSHA (Taysha)|QURE: Earnings growth in current year|MGTX - Expected net earnings per share growth this year|Net earnings per share growth this year RGNX|SLDB: Earnings per share increase in current year|Earnings per share growth in current year ocugen.com (OCGN)|Expected net earnings per share growth this year PacBio Corp|Earnings per share growth in current year Benitec Biopharma BNTC|DSGN: Earnings per share growth this year|RCKT - Earnings per share growth in current year|4dmoleculartherapeutics.com (FDMT) - Net earnings per share growth this year|lexeotx.com (LXEO) - Earnings per share growth in current year|Korro Bio, Inc (KRRO) - Earnings growth in current year|EDIT (editasmedicine.com) - Earnings growth in current year|Earnings per share growth this year SLN (silence-therapeutics.com)|Earnings per share growth in current year proqr.com (PRQR)|Codexis - Earnings per share growth this year|Earnings growth in current year SGMO (Sangamo Therapeutics)|Earnings growth in current year nautilus.bio NAUT|Metagenomi Inc. - Earnings growth in current year|DTIL (Precision BioSciences Inc.) - Earnings per share growth this year|GBIO: Earnings growth in current year|Earnings per share growth rate in current year Boundless Bio, Inc (BOLD)|XCUR (Exicure) - Earnings growth in current year|Net earnings per share growth this year Imunon (IMNN)|Earnings growth in current year PHIO|Mustang Bio - Earnings per share growth this year|TransCode Therapeutics, Inc. - Net earnings per share growth this year|Expected net earnings per share growth this year Bionano Genomics, Inc. (BNGO)|APDN - Earnings per share growth in current year|Earnings per share increase in current year BLUE (Bluebird Bio)|ImmunoPrecise (IPA) - Earnings per share growth in current year|OMGA: Net earnings per one share growth for the current year|Earnings per share growth in current year Singular Genomics Systems, Inc.|Earnings growth in current year Regulus Therapeutics, Inc.|Net earnings per share growth this year SYRS (Syros)|TBIO - Earnings per share growth rate in current year|Earnings per share growth in current year TRACON Pharmaceuticals, Inc. TCON|Unity Biotechnology (UBX) - Earnings per share growth rate in current year